CTOs on the Move

Floyd Medical Center

www.floydmed.org

 
Floyd Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Floyd Medical Center is based in Rome, GA. You can find more information on Floyd Medical Center at www.floydmed.org
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion
  • www.floydmed.org
  • 304 Turner Mccall Blvd SW
    Rome, GA USA 30165
  • Phone: 706.509.5000

Executives

Name Title Contact Details

Similar Companies

YMCA of Southern Maine

The Y: Were for youth development, healthy living, and social responsibility

Eagle Hospital Physicians

Eagle Hospital Physicians is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Varian

Varian Medical Systems` vision is a world without fear of cancer. To meet this challenge, we equip the world with new tools for fighting cancer. Since the 1950s we have been producing tools that harness the power of X-ray energy to benefit humankind. Our history is one of pioneering developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. Today, we have a robust product portfolio and long-standing relationships with many of the world`s leading clinicians. As Varian continues to grow, our staff of over 6,500 people in 70 sales and support offices around the globe is developing innovative, cost-effective solutions that help make the world a healthier place. Varian reserves the right to remove any comment for any reason and ban any user from its page at is sole discretion. Varian does not endorse user comments on its page and cannot confirm their accuracy. User comments do not necessarily represent the ideas, thoughts, beliefs, opinions or views of Varian, or any of its affiliates.

Eleme Medical

Eleme Medical is a Merrimack, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.